EDIT Stock: Pioneering Genome Editing Technology – Profit Confidential
Profit Confidential |
EDIT Stock: Pioneering Genome Editing Technology
Profit Confidential One of our strategies for investing in high-growth stocks is to look for companies with cutting-edge technologies in emerging fields. A good example of an emerging field is genome editing, which holds lot of promise. There are few players trying to … ArQule (NASDAQ:ARQL) and Editas Medicine (EDIT) Financial … Financial Newsletter – Zacks |
